Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

DLKM, SIRI, CDII, ARNA, ESLR- DAILY STOCK REPORTS FROM STOCK-PR.COM

 

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

http://pennyomega.com/img/dlkm.jpg

Douglas Lake Minerals Inc. (OTCBB:DLKM) is pleased to provide an update regarding its recently acquired Handeni Project which is located in the rapidly developing region of eastern Tanzania. Douglas Lake Minerals’ 100% owned Handeni Project consists of four prospecting licenses covering approximately 800 km(2) which are directly adjacent to, and partly surround, Canaco Resources Inc’s (V.CAN) 200 km(2) Kilindi license which holds the Magambazi gold mineralization occurrence.

Douglas Lake Minerals is pleased to provide the results of the recent exploration program conducted on PLR PLR4973/2008, subsequently subdivided into four PL’s (PL6742/2010, PL6743/2010, PL6744/2010 and PL6779/2010), based on the outcomes of the first phase of the continuous exploration program conducted since 2008. This exploration phase included a fixed-wing aircraft flown aeromagnetic and radiometric survey at a line spacing of 200m and a height of 80m, subsequent interpretation of data and ground follow-up. The survey and interpretation was conducted according to internationally accepted standards by the Council for Geoscience, South Africa.

Phase two of the exploration program focused on the identified potential zones during an intensive stream sediment and soil sampling program. The results will be released in due course. Douglas Lake Minerals has requested a geologist to prepare a Technical Report on the Handeni Project in accordance with the provisions of National Instrument 43-101 (”NI 43-101?) of the Canadian Securities Administrators. Upon receipt of the Technical Report Douglas Lake Minerals will file it on SEDAR at sedar.com.

Douglas Lake Minerals is an emerging mineral exploration company focused on exploring mining opportunities in Tanzania.

http://pennyomega.com/img/siri.jpg

Sirius XM Radio (Nasdaq: SIRI) recently announced that it will provide comprehensive coverage of the 2011 golf season, offering more live play-by-play than any other TV or radio broadcaster and giving listeners nationwide access to the full schedule of events featuring the world’s best golfers.

(Logo: http://photos.prnewswire.com/prnh/20101014/NY82093LOGO )

SiriusXM will broadcast live play-by-play of the 2011 PGA TOUR season, featuring THE PLAYERS Championship (May 12-15 from TPC Sawgrass, FL), and all four major championship events — the Masters (April 7-10 from Augusta National Golf Club, GA), the U.S. Open Championship (June 16-19 from Congressional CC, MD), The Open Championship (July 14-17 from Royal St. George’s GC, Kent, England) and the PGA Championship (August 11-14 from Atlanta Athletic Club, GA).

SiriusXM’s coverage will also include the PGA TOUR Playoffs for the FedExCup: The Barclays (August 25-28 from Plainfield CC, NJ), Deutsche Bank Championship (September 2-5 from TPC Boston, MA), BMW Championship (September 15-18 from Cog Hill GC, IL) and THE TOUR Championship presented by Coca-Cola (September 22-25 from East Lake GC, GA).

Sirius and XM listeners will have access to hole-by-hole coverage every day of tournament play for each event, as well as expert analysis on the PGA TOUR Network channel, the only radio channel dedicated to professional golf.

Live tournament coverage and the PGA TOUR Network channel are available to all XM subscribers and to Sirius subscribers who purchase the “Best of XM” programming package, and are available nationwide on XM channel 146 and Sirius channel 209.

Play-by-play coverage of the U.S. Open Championship will air on ESPN Radio, Sirius channel 120 and XM channel 140.

Sirius and XM listeners will also be able to access live tournament play-by-play and the PGA TOUR Network channel online at www.sirius.com and www.xmradio.com as well as on the Apple iPhone, iPod Touch, BlackBerry and Android-powered mobile devices using the SiriusXM Premium Online App.

For more information, please visit www.xmradio.com or www.sirius.com.

China Direct Industries, Inc. (Nasdaq:CDII) announced that it has entered into definitive agreements to sell 2,222,223 shares of its common stock and warrants to purchase up to 777,778 shares of its common stock to accredited investors. The purchase price per share of the common stock will be $1.80. The warrants will have an exercise price of $2.00 per share and will be exercisable starting six months from the closing date for a period ending on the fifth anniversary of the initial exercise date. Management intends to use the proceeds from this offering for general working capital purposes to forward its magnesium distribution businesses in China as well as its metal ore trading projects in Mexico and South America. The shares and warrants described above are offered by China Direct Industries pursuant to a registration statement previously filed and declared effective by the Securities and Exchange Commission on August 1, 2008.
China Direct Industries, Inc. engages in the production and distribution of magnesium, and distributes basic materials in the People’s Republic of China. The company operates two main segments, Magnesium and Basic Materials.

Arena Pharmaceuticals, Inc. (Nasdaq:ARNA) announced the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA). "The meeting discussions reinforce our position that we have a path forward to seek FDA approval of lorcaserin," said Jack Lief, Arena's President and Chief Executive Officer. "Based on guidance we have received from the agency, we are executing several activities and expect to resubmit the lorcaserin NDA by the end of 2011. As we continue discussions with the FDA to refine elements of our plan, we may identify ways to shorten this timeline. We will provide more details about our plan on the conference call and webcast this morning."
Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.

Evergreen Solar Inc. (Nasdaq:ESLR) announced that it will affect the 1-for-6 reverse stock split previously approved by the Company's stockholders at the annual meeting of stockholders on July 27, 2010. The 1-for-6 reverse split of the Company’s common stock effective at 12:01 a.m. Eastern Standard Time, on Saturday, January 1, 2011. Due to the reverse stock split, Evergreen Solar’s common stock will trade under a new CUSIP number, 30033R306, and will temporarily trade under the symbol “ESLRD” for 20 trading days beginning January 3, 2011, after which time the symbol will revert to “ESLR.”
Evergreen Solar, Inc. develops, manufactures, and markets solar power products primarily in the United States and Europe. The company manufactures String Ribbon solar panels utilizing its proprietary wafer manufacturing technology, which involves a process to produce multi-crystalline silicon wafers by growing thin strips of silicon that are cut into wafers.

 

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

 

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

Be Sure To Visit stock-pr.ning.com

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.